XOMA

XOMA Corporation (NASDAQ:XOMA) is a biotechnology royalty aggregator founded in 1981 and headquartered in Emeryville, California. The company went public in 1986 and has evolved from a traditional biotechnology company into a specialized investment firm that acquires and manages royalty interests in pre-commercial therapeutic candidates. Rather than developing drugs internally, XOMA focuses on building a diversified portfolio of approximately 70 assets by purchasing the future economic rights to promising biotech treatments that have been licensed to pharmaceutical or biotechnology partners for development and commercialization.